Live tape
Top 8, mentions 7d15,739MSFT3,098 mentions▲ +0.09GOOGL2,177 mentions▲ +0.05AAPL2,131 mentions▲ +0.07META2,089 mentions▲ +0.04SNDK1,844 mentions▲ +0.06NVDA1,604 mentions▲ +0.07SPCX1,560 mentions▲ +0.06QQQ1,236 mentions▲ +0.04

Equity · Healthcare

EHC

Encompass Health Corporation · NYSE

$112.00 −0.45% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView

The chart above plots the price of EHC over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 54 sessions over that window: $107.00 on 4 May 2026 through $112.00 on 17 July 2026. Finazon · prior-day close.

Market cap $11.1B
P/E (TTM) 18.5
52-week range $94.00 – $127.14
Avg volume 249.5K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

EHC insider trades

SEC Form 4 · last 90 days · newest reported trade 16 Jul 2026
Open-market buys 0
Open-market sells 2
Net sold $3.03M
Non-trade filings 21

Showing the 12 most recent of 23 filings in this window. The figures above count all of them.

Compensation mechanics (12 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
16 Jul 2026 Christie Edward M III Director Award 248 $28K
16 Jul 2026 Reidy Christopher R Director Award 319 $36K
15 Jul 2026 CARMICHAEL GREG D Director Award 29
15 Jul 2026 Christie Edward M III Director Award 11
15 Jul 2026 Hayes Cain A Director Award 4
15 Jul 2026 HERMAN JOAN E Director Award 85
15 Jul 2026 KATZ LESLYE G Director Award 85
15 Jul 2026 O'Connor Kevin J. Director Award 19
15 Jul 2026 SCHLICHTING NANCY M Director Award 40
15 Jul 2026 Williams Terrance Director Award 29
15 Jul 2026 Reidy Christopher R Director Award 21
15 May 2026 COLTHARP DOUGLAS E EVP & Chief Financial Officer Option exercise 27,694 $912K

EHC reported financials

SEC EDGAR XBRL

EHC reported revenue of $5.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was $566.2M.

Figure Reported Period
Revenue $5.9B 31 Dec 2025 fiscal year
Net income $566.2M 31 Dec 2025 fiscal year
Diluted EPS $5.54 31 Dec 2025 fiscal year
Total assets $7.3B 31 Mar 2026 at period end
Total equity $2.5B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

EHC earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $1.93
31 Dec 2025 FY 2025 $5.54
30 Sep 2025 Q3 2025 $1.24
30 Jun 2025 Q2 2025 $1.39

Reported figures & scheduled dates · SEC EDGAR filings

EHC institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a EHC position for the quarter ended 31 Mar 2026 — a combined $497.3M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Two Sigma Investments Added +176.1% shares 2,222,101 $214.9M
D. E. Shaw & Co. Added +67.1% shares 565,355 $54.7M
Citadel Advisors Added +335.8% shares 511,887 $49.5M
AQR Capital Management Held (±25%) −13.3% shares 500,604 $48.4M
Millennium Management Trimmed −66.7% shares 477,819 $46.2M
Marshall Wace Added +1,893.7% shares 297,635 $28.8M
Renaissance Technologies Added +288.6% shares 265,000 $25.6M
Man Group Added +123.8% shares 164,466 $15.9M
Balyasny Asset Management Trimmed −85.9% shares 53,859 $5.2M
Bridgewater Associates Added +31.1% shares 46,415 $4.5M

Source: SEC EDGAR 13F filings